First prospective multicenter U.S.-based trial for indication expansion of SIR-Spheres ® Y-90 resin microspheres taking place in 15 sites across the U.S. WOBURN, Mass., May 10, 2021 /CNW/ -- Sirtex ...
Sirtex announces SIR-Spheres ® portfolio expansion to include the FLEXdose SELECT 3mL vial configuration allowing for more patient-specific Y-90 selective treatment plans ...
It took nearly 25 years, but advances in technology — an investigator’s insight — and a device company’s “leap of faith” have led to a major step forward in the treatment of unresectable ...
Expanded indication makes SIR-Spheres ® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma and metastatic colorectal cancer WOBURN, ...
Chicago, IL, USA (30 May 2015) -- The benefits of adding liver-directed SIR-Spheres Y-90 resin microspheres to a current systemic chemotherapy for the first-line treatment of unresectable metastatic ...
Sirtex brings an innovative liver cancer treatment delivery system to Europe, enhancing options for physicians and their patients. WOBURN, Mass., Sept. 16, 2024 /PRNewswire/ -- Sirtex Medical ("Sirtex ...
Metastasectomy or radiofrequency ablation for treatment for colorectal cancer liver metastasis: Comparison of recurrence rates and identification of risk factors for local recurrence. This is an ASCO ...
Sirtex Medical says HY worldwide dose sales of sir-spheres Y-90 resin microspheres increased 5.6 pct
China will reduce import tariffs on ethane and certain recycled copper and aluminium raw materials from next year, the government said on Saturday. category Wall St finishes down after sell-off at end ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results